[HTML][HTML] Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with gastric cancer
S Savabkar, P Azimzadeh, V Chaleshi… - … and hepatology from …, 2013 - ncbi.nlm.nih.gov
Gastroenterology and hepatology from bed to bench, 2013•ncbi.nlm.nih.gov
Aim This study aimed to determine the association between PD-1.5 C/T (rs2227981,+ 7785)
and the risk of gastric cancer (GC) in an Iranian population. Background Gastric cancer is
the fourth most common cancer in the world. The programmed death 1 (PD-1) is a member
of the CD28 super family. PD-1 is a negative regulator of T-cell effector mechanisms which
decrease immune responses against cancer.
and the risk of gastric cancer (GC) in an Iranian population. Background Gastric cancer is
the fourth most common cancer in the world. The programmed death 1 (PD-1) is a member
of the CD28 super family. PD-1 is a negative regulator of T-cell effector mechanisms which
decrease immune responses against cancer.
Abstract
Aim
This study aimed to determine the association between PD-1.5 C/T (rs2227981,+ 7785) and the risk of gastric cancer (GC) in an Iranian population.
Background
Gastric cancer is the fourth most common cancer in the world. The programmed death 1 (PD-1) is a member of the CD28 super family. PD-1 is a negative regulator of T-cell effector mechanisms which decrease immune responses against cancer.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果